The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
GISAID’s Role in Pandemic Response
Open accessAbstract
GISAID is a global data science initiative and the primary source of genomic and associated metadata of all influenza viruses, Respiratory Syncytial Virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pandemic coronavirus causing coronavirus disease 2019 (COVID-19).GISAID's publicly accessible data sharing platform enables collaboration of over 42,000 participating researchers from 198 nations and data generators from over 3,500 institutions across the globe.Since the first wholegenome sequences were made available by China CDC through GISAID on January 10, 2020, over 5 million genetic sequences of SARS-CoV-2 from 194 countries and territories have been made publicly available through GISAID's EpiCoV database as of November 9, 2021.This high-quality, curated data enabled the rapid development of diagnostic and prophylactic measures against SARS-CoV-2 including the first diagnostic tests and the first vaccines to combat COVID-19 as well as continuous monitoring of emerging variants in near real-time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Data, disease and diplomacy: GISAID's innovative contribution to global health
Elbe, S., & Buckland‐Merrett, G. (2017) · Global Challenges · doi:10.1002/gch2.1018 · Cited by 1,928
A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020
Tan, W., MHC Key Laboratory of Biosafety, N. I. F. V. D. C. A. P., Zhao, X., Ma, X., Wang, W., Niu, P., Xu, W., F. Gao, G., Wu, G., & Center for Biosafety Mega-Science, C. A. O. S. (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.017 · Cited by 741
IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection
Bohn, M. K., Mancini, N., Loh, T. P., Wang, C.-B., Grimmler, M., Gramegna, M., Yuen, K., Mueller, R., Koch, D. D., Sethi, S. K., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1412 · Cited by 49
Cited by
Markov, P. V., Ghafari, M., Beer, M., Lythgoe, K., Simmonds, P., Stilianakis, N. I., & Katzourakis, A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00878-2 · Cited by 1,179
Gangavarapu, K., Latif, A. A., Mullen, J. L., Alkuzweny, M., Hufbauer, E., Tsueng, G., Haag, E., Zeller, M., Aceves, C. M., Zaiets, K., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-01769-3 · Cited by 394
Self-citationVirological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Yamasoba, D., Kimura, I., Nasser, H., Morioka, Y., Nao, N., Ito, J., Uriu, K., Tsuda, M., Zahradnik, J., Shirakawa, K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.035 · Cited by 380
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
Muik, A., Lui, B. G., Wallisch, A.-K., Bacher, M., Mühl, J., Reinholz, J., Ozhelvaci, O., Beckmann, N., Güimil Garcia, R. D. L. C., Poran, A., et al. (2022) · Science · doi:10.1126/science.abn7591 · Cited by 367
Early computational detection of potential high-risk SARS-CoV-2 variants
(2023) · doi:10.1016/j.compbiomed.2023.106618 · Cited by 46
Metadata
- Authors
- Khare, S., GISAID Global Data Science Initiative (GISAID), M., Gurry, C., Freitas, L., B Schultz, M., Bach, G., Diallo, A., Akite, N., Ho, J., TC Lee, R., Yeo, W., Core Curation Team, G., Maurer-Stroh, S., Bioinformatics Institute, A. F. S. T. A. R., Oswaldo Cruz Foundation (FIOCRUZ), R. D. J., Institut Pasteur de Dakar, D., National Institutes of Biotechnology Malaysia, S., Smorodintsev Research Institute of Influenza, S. P., Genome Institute of Singapore, A. F. S. T. A. R., China National GeneBank, S., A*STAR Infectious Disease Labs (ID Labs), S., National Public Health Laboratory, N. C. F. I. D., & Department of Biological Sciences, N. U. O. S.
- Venue
- China CDC Weekly
- Published
- 2021
- Volume
- 3
- Issue
- 49
- Pages
- 1049-1051
- ISSN
- 2096-7071 (ISSN-L)
- OpenAlex
- W4200137031
- Cited by
- 1,054
- References
- 5
- FWCI
- 59.15
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GISAID’s Role in Pandemic Response. https://app.cochat.ai/papers/10.46234/ccdcw2021.255
- The paper
- Khare, S., GISAID Global Data Science Initiative (GISAID), M., Gurry, C., Freitas, L., B Schultz, M., Bach, G., Diallo, A., Akite, N., Ho, J., TC Lee, R., Yeo, W., Core Curation Team, G., Maurer-Stroh, S., Bioinformatics Institute, A. F. S. T. A. R., Oswaldo Cruz Foundation (FIOCRUZ), R. D. J., Institut Pasteur de Dakar, D., National Institutes of Biotechnology Malaysia, S., Smorodintsev Research Institute of Influenza, S. P., Genome Institute of Singapore, A. F. S. T. A. R., . . . Department of Biological Sciences, N. U. O. S. (2021). GISAID’s Role in Pandemic Response. China CDC Weekly. https://doi.org/10.46234/ccdcw2021.255
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.